Table of Contents 1 Market Overview 1.1 Immune Checkpoint Inhibitors Introduction 1.2 Market Analysis by Type 1.2.1 PD-1/PD-L1 1.2.2 CTLA-4 1.3 Market Analysis by Applications 1.3.1 Lung Cancer 1.3.2 Colorectal Cancer 1.3.3 Breast Cancer 1.3.4 Prostate Cancer 1.3.5 Melanoma 1.3.6 Blood Cancer 1.3.7 Other 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Bristol Myer Squibb 2.1.1 Business Overview 2.1.2 Immune Checkpoint Inhibitors Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Bristol Myer Squibb Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 AstraZeneca 2.2.1 Business Overview 2.2.2 Immune Checkpoint Inhibitors Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 AstraZeneca Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Merck & Co. 2.3.1 Business Overview 2.3.2 Immune Checkpoint Inhibitors Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Merck & Co. Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Roche / Genentech 2.4.1 Business Overview 2.4.2 Immune Checkpoint Inhibitors Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Roche / Genentech Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Incyte Corporation 2.5.1 Business Overview 2.5.2 Immune Checkpoint Inhibitors Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Incyte Corporation Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 NewLink Genetics 2.6.1 Business Overview 2.6.2 Immune Checkpoint Inhibitors Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 NewLink Genetics Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 ArGEN-X 2.7.1 Business Overview 2.7.2 Immune Checkpoint Inhibitors Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 ArGEN-X Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Seattle Genetics 2.8.1 Business Overview 2.8.2 Immune Checkpoint Inhibitors Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Seattle Genetics Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Pfizer 2.9.1 Business Overview 2.9.2 Immune Checkpoint Inhibitors Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Pfizer Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 MacroGenics 2.10.1 Business Overview 2.10.2 Immune Checkpoint Inhibitors Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 MacroGenics Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.11 Celldex Therapeutics 2.11.1 Business Overview 2.11.2 Immune Checkpoint Inhibitors Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Celldex Therapeutics Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.12 CureTech 2.12.1 Business Overview 2.12.2 Immune Checkpoint Inhibitors Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 CureTech Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.13 Immutep 2.13.1 Business Overview 2.13.2 Immune Checkpoint Inhibitors Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Immutep Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.14 Innate Pharma 2.14.1 Business Overview 2.14.2 Immune Checkpoint Inhibitors Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 Innate Pharma Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.15 Sorrento Therapeutics 2.15.1 Business Overview 2.15.2 Immune Checkpoint Inhibitors Type and Applications 2.15.2.1 Product A 2.15.2.2 Product B 2.15.3 Sorrento Therapeutics Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.16 GlaxoSmithKline 2.16.1 Business Overview 2.16.2 Immune Checkpoint Inhibitors Type and Applications 2.16.2.1 Product A 2.16.2.2 Product B 2.16.3 GlaxoSmithKline Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.17 GITR, Inc 2.17.1 Business Overview 2.17.2 Immune Checkpoint Inhibitors Type and Applications 2.17.2.1 Product A 2.17.2.2 Product B 2.17.3 GITR, Inc Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Immune Checkpoint Inhibitors Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017) 3.1 Global Immune Checkpoint Inhibitors Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Immune Checkpoint Inhibitors Revenue and Market Share by Manufacturer (2016-2017) 3.3 Market Concentration Rate 3.3.1 Top 3 Immune Checkpoint Inhibitors Manufacturer Market Share in 2017 3.3.2 Top 6 Immune Checkpoint Inhibitors Manufacturer Market Share in 2017 3.4 Market Competition Trend 4 Global Immune Checkpoint Inhibitors Market Analysis by Regions 4.1 Global Immune Checkpoint Inhibitors Sales, Revenue and Market Share by Regions 4.1.1 Global Immune Checkpoint Inhibitors Sales and Market Share by Regions (2013-2018) 4.1.2 Global Immune Checkpoint Inhibitors Revenue and Market Share by Regions (2013-2018) 4.2 North America Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 4.3 Europe Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 4.4 Asia-Pacific Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 4.5 South America Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 4.6 Middle East and Africa Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 5 North America Immune Checkpoint Inhibitors by Countries 5.1 North America Immune Checkpoint Inhibitors Sales, Revenue and Market Share by Countries 5.1.1 North America Immune Checkpoint Inhibitors Sales and Market Share by Countries (2013-2018) 5.1.2 North America Immune Checkpoint Inhibitors Revenue and Market Share by Countries (2013-2018) 5.2 United States Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 5.3 Canada Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 5.4 Mexico Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 6 Europe Immune Checkpoint Inhibitors by Countries 6.1 Europe Immune Checkpoint Inhibitors Sales, Revenue and Market Share by Countries 6.1.1 Europe Immune Checkpoint Inhibitors Sales and Market Share by Countries (2013-2018) 6.1.2 Europe Immune Checkpoint Inhibitors Revenue and Market Share by Countries (2013-2018) 6.2 Germany Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 6.3 UK Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 6.4 France Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 6.5 Russia Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 6.6 Italy Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 7 Asia-Pacific Immune Checkpoint Inhibitors by Countries 7.1 Asia-Pacific Immune Checkpoint Inhibitors Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Immune Checkpoint Inhibitors Sales and Market Share by Countries (2013-2018) 7.1.2 Asia-Pacific Immune Checkpoint Inhibitors Revenue and Market Share by Countries (2013-2018) 7.2 China Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 7.3 Japan Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 7.4 Korea Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 7.5 India Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 7.6 Southeast Asia Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 8 South America Immune Checkpoint Inhibitors by Countries 8.1 South America Immune Checkpoint Inhibitors Sales, Revenue and Market Share by Countries 8.1.1 South America Immune Checkpoint Inhibitors Sales and Market Share by Countries (2013-2018) 8.1.2 South America Immune Checkpoint Inhibitors Revenue and Market Share by Countries (2013-2018) 8.2 Brazil Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 8.3 Argentina Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 8.4 Colombia Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 9 Middle East and Africa Immune Checkpoint Inhibitors by Countries 9.1 Middle East and Africa Immune Checkpoint Inhibitors Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Immune Checkpoint Inhibitors Sales and Market Share by Countries (2013-2018) 9.1.2 Middle East and Africa Immune Checkpoint Inhibitors Revenue and Market Share by Countries (2013-2018) 9.2 Saudi Arabia Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 9.3 UAE Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 9.4 Egypt Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 9.5 Nigeria Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 9.6 South Africa Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) 10 Global Immune Checkpoint Inhibitors Market Segment by Type 10.1 Global Immune Checkpoint Inhibitors Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Immune Checkpoint Inhibitors Sales and Market Share by Type (2013-2018) 10.1.2 Global Immune Checkpoint Inhibitors Revenue and Market Share by Type (2013-2018) 10.2 PD-1/PD-L1 Sales Growth and Price 10.2.1 Global PD-1/PD-L1 Sales Growth (2013-2018) 10.2.2 Global PD-1/PD-L1 Price (2013-2018) 10.3 CTLA-4 Sales Growth and Price 10.3.1 Global CTLA-4 Sales Growth (2013-2018) 10.3.2 Global CTLA-4 Price (2013-2018) 11 Global Immune Checkpoint Inhibitors Market Segment by Application 11.1 Global Immune Checkpoint Inhibitors Sales Market Share by Application (2013-2018) 11.2 Lung Cancer Sales Growth (2013-2018) 11.3 Colorectal Cancer Sales Growth (2013-2018) 11.4 Breast Cancer Sales Growth (2013-2018) 11.5 Prostate Cancer Sales Growth (2013-2018) 11.6 Melanoma Sales Growth (2013-2018) 11.7 Blood Cancer Sales Growth (2013-2018) 11.8 Other Sales Growth (2013-2018) 12 Immune Checkpoint Inhibitors Market Forecast (2018-2023) 12.1 Global Immune Checkpoint Inhibitors Sales, Revenue and Growth Rate (2018-2023) 12.2 Immune Checkpoint Inhibitors Market Forecast by Regions (2018-2023) 12.2.1 North America Immune Checkpoint Inhibitors Market Forecast (2018-2023) 12.2.2 Europe Immune Checkpoint Inhibitors Market Forecast (2018-2023) 12.2.3 Asia-Pacific Immune Checkpoint Inhibitors Market Forecast (2018-2023) 12.2.4 South America Immune Checkpoint Inhibitors Market Forecast (2018-2023) 12.2.5 Middle East and Africa Immune Checkpoint Inhibitors Market Forecast (2018-2023) 12.3 Immune Checkpoint Inhibitors Market Forecast by Type (2018-2023) 12.3.1 Global Immune Checkpoint Inhibitors Sales Forecast by Type (2018-2023) 12.3.2 Global Immune Checkpoint Inhibitors Market Share Forecast by Type (2018-2023) 12.4 Immune Checkpoint Inhibitors Market Forecast by Application (2018-2023) 12.4.1 Global Immune Checkpoint Inhibitors Sales Forecast by Application (2018-2023) 12.4.2 Global Immune Checkpoint Inhibitors Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Immune Checkpoint Inhibitors Picture Table Product Specifications of Immune Checkpoint Inhibitors Figure Global Sales Market Share of Immune Checkpoint Inhibitors by Types in 2017 Table Immune Checkpoint Inhibitors Types for Major Manufacturers Figure PD-1/PD-L1 Picture Figure CTLA-4 Picture Figure Immune Checkpoint Inhibitors Sales Market Share by Applications in 2017 Figure Lung Cancer Picture Figure Colorectal Cancer Picture Figure Breast Cancer Picture Figure Prostate Cancer Picture Figure Melanoma Picture Figure Blood Cancer Picture Figure Other Picture Figure United States Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Canada Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Germany Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure France Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure UK Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Russia Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Italy Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure China Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Japan Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Korea Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure India Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Immune Checkpoint Inhibitors Revenue (Value) and Growth Rate (2013-2023) Table Bristol Myer Squibb Basic Information, Manufacturing Base and Competitors Table Bristol Myer Squibb Immune Checkpoint Inhibitors Type and Applications Table Bristol Myer Squibb Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca Immune Checkpoint Inhibitors Type and Applications Table AstraZeneca Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Merck & Co. Basic Information, Manufacturing Base and Competitors Table Merck & Co. Immune Checkpoint Inhibitors Type and Applications Table Merck & Co. Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Roche / Genentech Basic Information, Manufacturing Base and Competitors Table Roche / Genentech Immune Checkpoint Inhibitors Type and Applications Table Roche / Genentech Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Incyte Corporation Basic Information, Manufacturing Base and Competitors Table Incyte Corporation Immune Checkpoint Inhibitors Type and Applications Table Incyte Corporation Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table NewLink Genetics Basic Information, Manufacturing Base and Competitors Table NewLink Genetics Immune Checkpoint Inhibitors Type and Applications Table NewLink Genetics Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table ArGEN-X Basic Information, Manufacturing Base and Competitors Table ArGEN-X Immune Checkpoint Inhibitors Type and Applications Table ArGEN-X Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Seattle Genetics Basic Information, Manufacturing Base and Competitors Table Seattle Genetics Immune Checkpoint Inhibitors Type and Applications Table Seattle Genetics Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Immune Checkpoint Inhibitors Type and Applications Table Pfizer Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table MacroGenics Basic Information, Manufacturing Base and Competitors Table MacroGenics Immune Checkpoint Inhibitors Type and Applications Table MacroGenics Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Celldex Therapeutics Basic Information, Manufacturing Base and Competitors Table Celldex Therapeutics Immune Checkpoint Inhibitors Type and Applications Table Celldex Therapeutics Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table CureTech Basic Information, Manufacturing Base and Competitors Table CureTech Immune Checkpoint Inhibitors Type and Applications Table CureTech Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Immutep Basic Information, Manufacturing Base and Competitors Table Immutep Immune Checkpoint Inhibitors Type and Applications Table Immutep Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Innate Pharma Basic Information, Manufacturing Base and Competitors Table Innate Pharma Immune Checkpoint Inhibitors Type and Applications Table Innate Pharma Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Sorrento Therapeutics Basic Information, Manufacturing Base and Competitors Table Sorrento Therapeutics Immune Checkpoint Inhibitors Type and Applications Table Sorrento Therapeutics Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline Immune Checkpoint Inhibitors Type and Applications Table GlaxoSmithKline Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table GITR, Inc Basic Information, Manufacturing Base and Competitors Table GITR, Inc Immune Checkpoint Inhibitors Type and Applications Table GITR, Inc Immune Checkpoint Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Immune Checkpoint Inhibitors Sales by Manufacturer (2016-2017) Figure Global Immune Checkpoint Inhibitors Sales Market Share by Manufacturer in 2016 Figure Global Immune Checkpoint Inhibitors Sales Market Share by Manufacturer in 2017 Table Global Immune Checkpoint Inhibitors Revenue by Manufacturer (2016-2017) Figure Global Immune Checkpoint Inhibitors Revenue Market Share by Manufacturer in 2016 Figure Global Immune Checkpoint Inhibitors Revenue Market Share by Manufacturer in 2017 Figure Top 3 Immune Checkpoint Inhibitors Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Immune Checkpoint Inhibitors Manufacturer (Revenue) Market Share in 2017 Figure Global Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Global Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018) Table Global Immune Checkpoint Inhibitors Sales by Regions (2013-2018) Table Global Immune Checkpoint Inhibitors Sales Market Share by Regions (2013-2018) Table Global Immune Checkpoint Inhibitors Revenue by Regions (2013-2018) Figure Global Immune Checkpoint Inhibitors Revenue Market Share by Regions in 2013 Figure Global Immune Checkpoint Inhibitors Revenue Market Share by Regions in 2017 Figure North America Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Europe Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Asia-Pacific Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure South America Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Middle East and Africa Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure North America Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018) Table North America Immune Checkpoint Inhibitors Sales by Countries (2013-2018) Table North America Immune Checkpoint Inhibitors Sales Market Share by Countries (2013-2018) Figure North America Immune Checkpoint Inhibitors Sales Market Share by Countries in 2013 Figure North America Immune Checkpoint Inhibitors Sales Market Share by Countries in 2017 Table North America Immune Checkpoint Inhibitors Revenue by Countries (2013-2018) Table North America Immune Checkpoint Inhibitors Revenue Market Share by Countries (2013-2018) Figure North America Immune Checkpoint Inhibitors Revenue Market Share by Countries in 2013 Figure North America Immune Checkpoint Inhibitors Revenue Market Share by Countries in 2017 Figure United States Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Canada Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Mexico Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Europe Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018) Table Europe Immune Checkpoint Inhibitors Sales by Countries (2013-2018) Table Europe Immune Checkpoint Inhibitors Sales Market Share by Countries (2013-2018) Table Europe Immune Checkpoint Inhibitors Revenue by Countries (2013-2018) Figure Europe Immune Checkpoint Inhibitors Revenue Market Share by Countries in 2016 Figure Europe Immune Checkpoint Inhibitors Revenue Market Share by Countries in 2017 Figure Germany Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure UK Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure France Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Russia Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Italy Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Asia-Pacific Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018) Table Asia-Pacific Immune Checkpoint Inhibitors Sales by Countries (2013-2018) Table Asia-Pacific Immune Checkpoint Inhibitors Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Immune Checkpoint Inhibitors Sales Market Share by Countries 2017 Table Asia-Pacific Immune Checkpoint Inhibitors Revenue by Countries (2013-2018) Figure Asia-Pacific Immune Checkpoint Inhibitors Revenue Market Share by Countries 2017 Figure China Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Japan Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Korea Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure India Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Southeast Asia Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure South America Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018) Table South America Immune Checkpoint Inhibitors Sales by Countries (2013-2018) Table South America Immune Checkpoint Inhibitors Sales Market Share by Countries (2013-2018) Figure South America Immune Checkpoint Inhibitors Sales Market Share by Countries in 2017 Table South America Immune Checkpoint Inhibitors Revenue by Countries (2013-2018) Table South America Immune Checkpoint Inhibitors Revenue Market Share by Countries (2013-2018) Figure South America Immune Checkpoint Inhibitors Revenue Market Share by Countries in 2017 Figure Brazil Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Argentina Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Colombia Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Middle East and Africa Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018) Table Middle East and Africa Immune Checkpoint Inhibitors Sales by Countries (2013-2018) Table Middle East and Africa Immune Checkpoint Inhibitors Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Immune Checkpoint Inhibitors Sales Market Share by Countries in 2017 Table Middle East and Africa Immune Checkpoint Inhibitors Revenue by Countries (2013-2018) Table Middle East and Africa Immune Checkpoint Inhibitors Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Immune Checkpoint Inhibitors Revenue Market Share by Countries in 2013 Figure Middle East and Africa Immune Checkpoint Inhibitors Revenue Market Share by Countries in 2017 Figure Saudi Arabia Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure UAE Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Egypt Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure Nigeria Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Figure South Africa Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018) Table Global Immune Checkpoint Inhibitors Sales by Type (2013-2018) Table Global Immune Checkpoint Inhibitors Sales Share by Type (2013-2018) Table Global Immune Checkpoint Inhibitors Revenue by Type (2013-2018) Table Global Immune Checkpoint Inhibitors Revenue Share by Type (2013-2018) Figure Global PD-1/PD-L1 Sales Growth (2013-2018) Figure Global PD-1/PD-L1 Price (2013-2018) Figure Global CTLA-4 Sales Growth (2013-2018) Figure Global CTLA-4 Price (2013-2018) Table Global Immune Checkpoint Inhibitors Sales by Application (2013-2018) Table Global Immune Checkpoint Inhibitors Sales Share by Application (2013-2018) Figure Global Colorectal Cancer Sales Growth (2013-2018) Figure Global Breast Cancer Sales Growth (2013-2018) Figure Global Prostate Cancer Sales Growth (2013-2018) Figure Global Melanoma Sales Growth (2013-2018) Figure Global Blood Cancer Sales Growth (2013-2018) Figure Global Other Sales Growth (2013-2018) Figure Global Immune Checkpoint Inhibitors Sales, Revenue and Growth Rate (2018-2023) Table Global Immune Checkpoint Inhibitors Sales Forecast by Regions (2018-2023) Table Global Immune Checkpoint Inhibitors Market Share Forecast by Regions (2018-2023) Figure North America Sales Immune Checkpoint Inhibitors Market Forecast (2018-2023) Figure Europe Sales Immune Checkpoint Inhibitors Market Forecast (2018-2023) Figure Asia-Pacific Sales Immune Checkpoint Inhibitors Market Forecast (2018-2023) Figure South America Sales Immune Checkpoint Inhibitors Market Forecast (2018-2023) Figure Middle East and Africa Sales Immune Checkpoint Inhibitors Market Forecast (2018-2023) Table Global Immune Checkpoint Inhibitors Sales Forecast by Type (2018-2023) Table Global Immune Checkpoint Inhibitors Market Share Forecast by Type (2018-2023) Table Global Immune Checkpoint Inhibitors Sales Forecast by Application (2018-2023) Table Global Immune Checkpoint Inhibitors Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Bristol Myer Squibb AstraZeneca Merck & Co. Roche / Genentech Incyte Corporation NewLink Genetics ArGEN-X Seattle Genetics Pfizer MacroGenics Celldex Therapeutics CureTech Immutep Innate Pharma Sorrento Therapeutics GlaxoSmithKline GITR, Inc